Skip to content

Medical emergency? What to do

Antidepressants linked to suicide risk in elderly

3-RXPublished June 14, 20062 min read

Key points

  • The risk of suicide among older patients appears to be increased during the first month of therapy with selective serotonin reuptake inhibitor (SSRI) antidepressants, but this increased risk is fairly low, researchers in Canada report.
  • A total of 1138 individuals who suicide were identified and these individuals were closely matched to 4,552 subjects who served as comparison group, according to the team's report in the American Journal of Psychiatry.
  • This risk was still seen after factoring in the effects of a recent depression diagnosis or previous psychiatric care.
  • "Several mechanisms may underlie the association between SSRI antidepressants and suicide," Juurlink and colleagues note.

The risk of suicide among older patients appears to be increased during the first month of therapy with selective serotonin reuptake inhibitor (SSRI) antidepressants, but this increased risk is fairly low, researchers in Canada report.

Dr. David N. Juurlink, of the Institute for Clinical Evaluative Sciences, Toronto, and colleagues examined coroner's data, along with data on prescriptions, physician billing claims and hospitalization, for more than 1.2 million subjects who were at least 66 years of age between 1992 and 2000.

A total of 1138 individuals who suicide were identified and these individuals were closely matched to 4,552 subjects who served as comparison group, according to the team's report in the American Journal of Psychiatry.

Compared with other antidepressants, SSRIs were associated with a nearly fivefold increased risk of completed suicide during the first month of therapy. In the first 30 days of treatment, 62 patients on an SSRI committed suicide compared with 17 suicides among patients who were prescribed another type of antidepressant drug.

This risk was still seen after factoring in the effects of a recent depression diagnosis or previous psychiatric care. Suicide of a violent nature was also more common among patients on SSRI therapy compared with patients receiving other antidepressants.

However, no increased risk of suicide was observed during the second and subsequent months of SSRI antidepressant treatment.

"Several mechanisms may underlie the association between SSRI antidepressants and suicide," Juurlink and colleagues note.

"During initial therapy, the risk of suicide may increase as some aspects of depression resolve (e.g., psychomotor retardation), thereby energizing the patient to suicide," they note. The patients may also develop feelings of restlessness during SSRI antidepressants, "which may increase the risk of suicide."

These findings differ from those reported online this week in the Public Library of Science Medicine journal. Researchers compared suicide rates in the U.S. in the last 14 years with the use of an SSRI antidepressant during the same period. They found that as the number of fluoxetine (Prozac) prescriptions increased, the number of suicides decreased.

However, the researchers add that their findings don't preclude an increased suicide risk in small populations, and recommend that the relationship between suicide and SSRI drug treatment should be further examined.

SOURCE: American Journal of Psychiatry, May 2006.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.